Rowen (not his real name) decided to create a Facebook group dedicated to raising public awareness about liver-related illnesses. Diagnosed with hepatitis B about eight years ago and now in the ...
Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...
Barr virus—but new research reveals how it can hijack immune cells, sparking a chronic disease that attacks the body from ...
Despite the WHO's 2030 goal to eliminate Hepatitis B and C, many remain untested due to misconceptions and lack of awareness.
According to the World Health Organization, approximately 304 million people worldwide are living with chronic hepatitis B or ...
Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...
Bluejay Therapeutics Inc.’s lead compound, the fully human monoclonal antibody brelovitug (BJT-778), produced positive virologic response data in the company’s phase II study of chronic hepatitis D ...